Australia's most trusted
source of pharma news
Tuesday, 25 November 2025
Tuesday, 25 November 2025
Subscribe
Login
Billion dollar 'No' for Lilly drug
MSAC has dealt a blow to Eli Lilly in its efforts to provide a ground-breaking drug to the Australian population, failing to support public funding for necessary tests which have an estimated price tag of a billion dollars over six years.
Omico warns of mates left behind
Precision oncology can extend life expectancy by half, but only one in five Aussies have access through the current referral system
TODAY
Compounders target Novartis
Pharma leapfrogged by a compounder to government funding for a copycat that does not have TGA approval
TODAY
Who'll nab 2025's last PBS listings?
December PBS listings will mark the final reimbursement wins for 2025 and a dozen drugs are jostling for success
24 November
Three blockbusters-to-be hit TGA
Drugs with big sales predictions, including a mega-blockbuster, have landed on the ARTG in a busy week for approvals
24 November Approvals Action
$275 blunder opens huge market
Who forgot to pay a tiny patent maintenance fee, paving the way for generics to enter the monster obesity market?
21 November
AI threat no one is talking about
Australian pharma coach is warning of a deeper disruption to the workplace than job losses if guardrails aren't put in place
21 November
Latest Jobs
Freight & Distribution SpecialistWarehouse AssistantFinance Business PartnerTechnical Service & Warehouse CoordinatorCompliance & Legal DirectorSenior Portfolio Director - Clinical Research, ChinaAssociate Business Development Director - Clinical Research, JapanCustomer Service Representative28 more...
Pharma in Focus Jobs
Sales & Customer Relations (14)
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Customer Service Representative - East Brisbane
- Head of Sales - Melbourne, VIC
- Pharmaceutical Sales Representative - Sydney
- Key Account Manager - Brisbane
- Clinical Sales Specialist - Sydney
- Clinical Sales Specialist - Melbourne
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Representative - Belrose
- Customer Service Representative - St Leonards
- Customer Service Representative - Belrose
- Inside Sales - Sydney
- Customer Service Representative - Macquarie Park
- Key Account Manager - Sydney
Clinical & Medical, R&D (6)
- Senior Portfolio Director - Clinical Research, China - Shanghai, China
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Clinical Sales Specialist - Sydney
- Clinical Sales Specialist - Melbourne
- Clinical Affairs Lead - Sydney
- QC Microbiologist - Broadmeadows
Regulatory, Pharmacovigilance & QA (5)
- Regulatory Affairs Specialist - Sydney
- Senior Quality Assurance Associate - Sydney
- Senior Regulatory Affairs Associate - Sydney
- Quality assurance associate - Sydney
- Pharmacovigilance Associate - Sydney
Executive Roles (3)
- Compliance & Legal Director - Macquarie Park
- Senior Portfolio Director - Clinical Research, China - Shanghai, China
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
Other (14)
- Freight & Distribution Specialist - Macquarie Park
- Warehouse Assistant - Rydalmere
- Finance Business Partner - Surry Hills
- Technical Service & Warehouse Coordinator - Alexandria
- Senior Payroll Officer - Melbourne
- Head of People and Culture - Kingsgrove
- TM - QLD South Consumables - Brisbane
- Commercial Lead - Melbourne
- Senior Recruitment Consultant - Sydney
- Senior Recruitment Consultant - Sydney
- Warehouse Assistant - Macquarie Park
- People and Culture Manager - Kingsgrove
- Technical Service & Warehouse Coordinator - Alexandria
- Service Administrator - Belrose
Doctor calls out $7 Rep sandwich
Critics flamed for questioning the integrity of doctors who accept a pen or a meal alongside pharma medical education
TODAY
Combo proves 'practice-changing'
FDA approves a big-name combo as the first perioperative treatment that improves survival for some types of bladder cancer
TODAY
'Fiasco sale' damages deal-making
With the Treasurer handing a US pharma a 'get out of jail free' card, questions are being asked how it will affect future pharma deals in Australia
24 November
AbbVie lifts lid on cancer burden
New report exposes urgent need to address the heavy toll inflicted on patients, families, communities and the economy
24 November
First 'Trojan Horse' drug wins nod
First-in-class drug ticked by the Regulator unlocks a new way of treating blood cancers, killing diseased cells from the inside
24 November
Pharma votes for Best Workplace
ICYMI: See which company has been ranked the best place to work by pharma professionals plus the other top stories this week
21 November Your Week in 5 Minutes
Boost for multi-cancer funding
Strong results of a combination treatment across a variety of cancers highlights the need for broad cancer listings on the PBS
21 November
Trial points to better treatment
Study reveals the potential for more precise imaging of kidney cancer cells, allowing doctors to make better treatment choices
21 November
Best in Aussie Med Affairs gonged
Two new awards were launched at the MAPA Excellence Awards this year, which recognised six outstanding medical affairs professionals
20 November
March PBAC Agenda drops early
When PBAC meets in March, 32 companies will be chasing the first recommendations for 2026. See who's on the list
20 November
Blooms sets blistering pace
Hits major milestone with the recycling of 20 million blister packs, keeping more than 30,000kg of aluminum and plastic out of landfill
20 November
Top drugs expanding their patch
At the first meeting for 2026, PBAC will consider 22 changes to listings, almost half to add new disease indications
20 November
Mega-drug clears hurdle for listing
With a PBAC recommendation already under its belt, the TGA approval for this next-gen treatment has cleared the way for listing
20 November
Which pharma hit AFR Fast 100?
This pharma found a niche of unmet need, and by filling it has been recognised as one of our fastest-growing companies
19 November